Location: New York, NY
CIK: 0002052213 · Show all filings
Period: Q2 2026 (← Previous)
Filing Date: Aug 14, 2026
Total Value: $398M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| COGT | COGENT BIOSCIENCES INC | 1,170,740 | $45.31M | 11.4% | — | — | COM | 19240Q201 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,855,000 | $40.55M | 10.2% | — | — | COM | 87164F105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 990,000 | $36.84M | 9.3% | — | — | COM NEW | 15117B202 |
| RLAY | RELAY THERAPEUTICS INC | 1,465,279 | $27.42M | 6.9% | — | — | COM | 75943R102 |
| PCVX | VAXCYTE INC | 452,340 | $26.29M | 6.6% | — | — | COM | 92243G108 |
| VERA | VERA THERAPEUTICS INC | 436,518 | $18.73M | 4.7% | — | — | CL A | 92337R101 |
| PHVS | PHARVARIS N V | 525,750 | $18.18M | 4.6% | — | — | COM | N69605108 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 984,931 | $18.09M | 4.5% | — | — | COM | 92790C104 |
| CTMX | CYTOMX THERAPEUTICS INC. | 4,550,000 | $17.06M | 4.3% | — | — | COM | 23284F105 |
| TVTX | TRAVERE THERAPEUTICS INC | 292,600 | $16.62M | 4.2% | — | — | COM | 89422G107 |
| LEGN | LEGEND BIOTECH CORP | 570,569 | $16.48M | 4.1% | — | — | SPONSORED ADS | 52490G102 |
| BEAM | BEAM THERAPEUTICS INC | 476,338 | $16.35M | 4.1% | — | — | COM | 07373V105 |
| CGEM | CULLINAN THERAPEUTICS INC | 690,000 | $12.56M | 3.2% | — | — | COM | 230031106 |
| NRIX | NURIX THERAPEUTICS INC | 460,000 | $11.16M | 2.8% | — | — | COM | 67080M103 |
| KRYS | KRYSTAL BIOTECH INC | 22,000 | $8.177M | 2.1% | — | — | COM | 501147102 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 15,000 | $8.127M | 2.0% | — | — | COM | 91307C102 |
| SMMT | SUMMIT THERAPEUTICS INC | 493,820 | $7.195M | 1.8% | — | — | COM | 86627T108 |
| INSM | INSMED INC | 65,000 | $6.93M | 1.7% | — | — | COM PAR $.01 | 457669307 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 520,000 | $5.2M | 1.3% | — | — | COM | 09058V103 |
| MBX | MBX BIOSCIENCES INC | 91,000 | $5.023M | 1.3% | — | — | COM | 55287L101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 38,000 | $4.658M | 1.2% | — | — | COM | 74366E102 |
| URGN | UROGEN PHARMA LTD | 120,000 | $4.416M | 1.1% | — | — | COM | M96088105 |
| DBVT | DBV TECHNOLOGIES S A | 265,000 | $4.346M | 1.1% | — | — | SPONSORED ADS | 23306J309 |
| ALMS | ALUMIS INC | 130,000 | $3.658M | 0.9% | — | — | COM | 022307102 |
| SUPN | SUPERNUS PHARMACEUTICALS | 70,000 | $3.256M | 0.8% | — | — | COM | 868459108 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 47,000 | $2.689M | 0.7% | — | — | COM | 09061G101 |
| IMCR | IMMUNOCORE HLDGS PLC | 81,143 | $2.576M | 0.6% | — | — | ADS | 45258D105 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 112,000 | $2.012M | 0.5% | — | — | COM | 03237H101 |
| ALEC | ALECTOR INC | 900,000 | $1.809M | 0.5% | — | — | COM | 014442107 |
| SEPN | SEPTERNA INC | 49,444 | $1.656M | 0.4% | — | — | COM | 81734D104 |
| DSGN | DESIGN THERAPEUTICS INC | 107,900 | $1.561M | 0.4% | — | — | COM | 25056L103 |
| STRO | SUTRO BIOPHARMA INC | 32,037 | $1.064M | 0.3% | — | — | COM SHS | 869367201 |
| WVE | WAVE LIFE SCIENCES LTD | 177,846 | $1.033M | 0.3% | — | — | SHS | Y95308105 |
| TYRA | TYRA BIOSCIENCES INC | 20,000 | $639K | 0.2% | — | — | COM | 90240B106 |
| ENGN | ENGENE THERAPEUTICS INC | 210,000 | $363K | 0.1% | — | — | COM | 29286X101 |